Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
8 studies found for:    1710777 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: Ketamine
2 Recruiting Sub-dissociative Intranasal Ketamine for Pediatric Sickle Cell Pain Crises
Condition: Sickle Cell Disease
Interventions: Drug: Ketamine;   Drug: Normal Saline;   Other: Standard Pain Therapy;   Other: Pediatric Quality of Life - Sickle Cell Disease Module;   Other: Faces Pain Scale - Revised
3 Completed Single-center Prospective Evaluation of Sickle Cell Patient Care in the CHU Brugmann Emergency Department
Condition: Sickle Cell Disease
Interventions: Other: Satisfaction;   Other: Biological parameters;   Other: Pain management
4 Completed
Has Results
The Use of Warmed Saline in Vaso-occlusive Episodes
Conditions: Sickle Cell Disease;   Sickle Cell Crisis
Intervention: Device: Astoflo Plus fluid warmer
5 Withdrawn Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis
Conditions: Sickle Cell Disease;   Hb-SS Disease With Vasoocclusive Pain;   Hemoglobin SS Disease With Vasoocclusive Crisis;   Other Sickle Cell Disease With Vaso-Occlusive Pain;   Hemoglobin SS Disease With Crisis
Interventions: Drug: Abciximab;   Drug: Placebo;   Other: Intravenous hydration;   Drug: Ibuprofen;   Drug: Parenteral narcotic;   Other: Incentive spirometry;   Other: Supplemental oxygen
6 Completed Blood Flow and Pain Crises in People With Sickle Cell Disease
Condition: Sickle Cell Disease
7 Completed Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
Conditions: Sickle Cell Disease;   Chronic Kidney Disease;   Pulmonary Hypertension
Intervention: Drug: Erythropoietin and Hydroxyurea
8 Completed Cooperative Study of The Clinical Course of Sickle Cell Disease
Conditions: Anemia, Sickle Cell;   Blood Disease

Indicates status has not been verified in more than two years